Outcomes of 27 Gauge Microincision Vitrectomy Surgery for XXXX .

@entity1715 @entity548 @entity937 @entity1713 @entity1347 @entity2286 @entity260 @entity8814 @entity2790 @entity86 @entity3225
PURPOSE: To report the initial experience, clinical outcomes, and safety profile of 27 gauge pars plana vitrectomy ( @entity2286 ) in eyes with @entity1347 . DESIGN: Multicenter, retrospective, interventional case series. METHODS: setting: Private practice and tertiary care settings. STUDY POPULATION: Eyes undergoing 27 gauge @entity2286 for a vitreoretinal surgery indication. INTERVENTION: Three-port, transconjunctival 27 gauge @entity2286 . MAIN OUTCOME MEASURES: Change in visual acuity and occurrence of @entity260 with minimum follow-up of 90  days. RESULTS: Ninety-five eyes met the inclusion criteria. Surgical indications included epiretinal membrane (n  = 26), @entity1713 (n  = 14), full-thickness macular hole (n  = 11), @entity1713 with (n  = 7) or without (n  = 9) proliferative @entity1715 (PVR), @entity548 (n  = 10), vitreous opacities (n  = 8), @entity3225 (n  = 4), sub-silicone oil retinal detachment (n  = 3), retained lens material (n  = 1), submacular @entity548 (n  = 1), and aqueous misdirection (n  = 1). Mean logMAR visual acuity improved from 1.08    0.71 (20/240 Snellen equivalent) preoperatively to 0.53    0.65 (20/67 Snellen equivalent) postoperatively (P < .001). Mean follow-up was 144  days (median 127  days, range 90-254  days). There were no intraoperative complications and no case required conversion to 20, 23, or 25 gauge instrumentation. A total of 3 sclerotomy sites (1.1%) were sutured at the conclusion of surgery. @entity260 included transient @entity2790 in 8 eyes (8.4%), transient @entity8814 in 5 eyes (5.3%), and @entity548 in 5 eyes (5.3%). No cases of @entity86 , sclerotomy-related @entity937 , or @entity1713 were encountered in the follow-up period. CONCLUSION: The 27 gauge @entity2286 was well tolerated with low rates of @entity260 across varied surgical indications.
